{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:28:24Z","timestamp":1785803304290,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["426534"],"award-info":[{"award-number":["426534"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT - 169095"],"award-info":[{"award-number":["PJT - 169095"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-025-00515-z","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:49:12Z","timestamp":1744739352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single cell RNAseq to identify subpopulations of glial progenitors in iPSC-derived oligodendroglial lineage cultures"],"prefix":"10.1038","volume":"11","author":[{"given":"Gabriela J.","family":"Blaszczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio E. C.","family":"Piscopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor M.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Chapleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack P.","family":"Antel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"a020453","DOI":"10.1101\/cshperspect.a020453","volume":"8","author":"DE Bergles","year":"2015","unstructured":"Bergles, D. E. & Richardson, W. D. Oligodendrocyte development and plasticity. Cold Spring Harb. Perspect. Biol. 8, a020453 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1523\/JNEUROSCI.03-06-01289.1983","volume":"3","author":"MC Raff","year":"1983","unstructured":"Raff, M. C., Abney, E. R., Cohen, J., Lindsay, R. & Noble, M. Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J. Neurosci. 3, 1289\u20131300 (1983).","journal-title":"J. Neurosci."},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G","volume":"47","author":"R Reynolds","year":"1997","unstructured":"Reynolds, R. & Hardy, R. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J. Neurosci. Res. 47, 455\u2013470 (1997).","journal-title":"J. Neurosci. Res."},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.expneurol.2014.04.027","volume":"260","author":"AH Crawford","year":"2014","unstructured":"Crawford, A. H., Stockley, J. H., Tripathi, R. B., Richardson, W. D. & Franklin, R. J. Oligodendrocyte progenitors: adult stem cells of the central nervous system?. Exp. Neurol. 260, 50\u201355 (2014).","journal-title":"Exp. Neurol."},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","volume":"158","author":"TJ Yuen","year":"2014","unstructured":"Yuen, T. J. et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell 158, 383\u2013396 (2014).","journal-title":"Cell"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","volume":"35","author":"S Moyon","year":"2015","unstructured":"Moyon, S. et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. J. Neurosci. 35, 4\u201320 (2015).","journal-title":"J. Neurosci."},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1006\/dbio.1997.8597","volume":"188","author":"MS Rao","year":"1997","unstructured":"Rao, M. S. & Mayer-Proschel, M. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev. Biol. 188, 48\u201363 (1997).","journal-title":"Dev. Biol."},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1523\/JNEUROSCI.22-01-00248.2002","volume":"22","author":"N Gregori","year":"2002","unstructured":"Gregori, N., Pr\u00f6schel, C., Noble, M. & Mayer-Pr\u00f6schel, M. The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J. Neurosci. 22, 248\u2013256 (2002).","journal-title":"J. Neurosci."},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1523\/JNEUROSCI.19-03-01049.1999","volume":"19","author":"H Mi","year":"1999","unstructured":"Mi, H. & Barres, B. A. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J. Neurosci. 19, 1049\u20131061 (1999).","journal-title":"J. Neurosci."},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0012-1606(84)90060-5","volume":"106","author":"MC Raff","year":"1984","unstructured":"Raff, M. C., Abney, E. R. & Miller, R. H. Two glial cell lineages diverge prenatally in rat optic nerve. Dev. Biol. 106, 53\u201360 (1984).","journal-title":"Dev. Biol."},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"M Bradl","year":"2010","unstructured":"Bradl, M. & Lassmann, H. Oligodendrocytes: biology and pathology. Acta Neuropathol. 119, 37\u201353 (2010).","journal-title":"Acta Neuropathol."},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/neuro.05.005.2009","volume":"3","author":"I Jakovcevski","year":"2009","unstructured":"Jakovcevski, I., Filipovic, R., Mo, Z., Rakic, S. & Zecevic, N. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front. Neuroanat. 3, 5 (2009).","journal-title":"Front. Neuroanat."},{"key":"515_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0294-y","volume":"10","author":"K Choquet","year":"2017","unstructured":"Choquet, K. et al. Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation. Mol. Brain 10, 13 (2017).","journal-title":"Mol. Brain"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/glia.24524","volume":"72","author":"VEC Piscopo","year":"2024","unstructured":"Piscopo, V. E. C. et al. The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells. Glia 72, 1165\u20131182 (2024).","journal-title":"Glia"},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2006.11.019","volume":"52","author":"B Deneen","year":"2006","unstructured":"Deneen, B. et al. The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. Neuron 52, 953\u2013968 (2006).","journal-title":"Neuron"},{"key":"515_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).","journal-title":"BMC Genomics"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.stemcr.2024.03.002","volume":"19","author":"DJ Dennis","year":"2024","unstructured":"Dennis, D. J., Wang, B. S., Karamboulas, K., Kaplan, D. R. & Miller, F. D. Single-cell approaches define two groups of mammalian oligodendrocyte precursor cells and their evolution over developmental time. Stem Cell Rep. 19, 654\u2013672 (2024).","journal-title":"Stem Cell Rep."},{"key":"515_CR18","doi-asserted-by":"publisher","unstructured":"Chen, C. X. et al. A multistep workflow to evaluate newly generated iPSCs and their ability to generate different cell types. Methods Protoc. 4 https:\/\/doi.org\/10.3390\/mps4030050 (2021).","DOI":"10.3390\/mps4030050"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41467-020-14766-3","volume":"11","author":"K Van den Berge","year":"2020","unstructured":"Van den Berge, K. et al. Trajectory-based differential expression analysis for single-cell sequencing data. Nat. Commun. 11, 1201 (2020).","journal-title":"Nat. Commun."},{"key":"515_CR20","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation2, 100141 (2021).","journal-title":"Innovation"}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00515-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00515-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00515-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:49:13Z","timestamp":1744739353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00515-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00515-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.18.629204","asserted-by":"object"}]},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Bernard is\/was a consultant for Calico (2023-present), Orchard Therapeutics (2023), Passage Bio Inc (2020-2022), and Ionis (2019). She is\/was a site investigator for the Alexander\u2019s disease trial of Ionis (2021-present), Metachromatic leukodystrophy of Shire\/Takeda (2020-2021), Krabbe (2021-2023) and GM1 gene therapy trials of Passage Bio (2021-2024), GM1 natural history study from the University of Pennsylvania sponsored by Passage Bio (2021-present) and Adrenoleukodystrophy\/Hematopoietic stem cell transplantation natural history study of Bluebird Bio (2019), a site sub-investigator for the MPS II gene therapy trial of Regenxbio (2021-present) and the MPS II clinical trial of Denali (2022-present). She has received an unrestricted educational grant from Takeda (2021-2022). She serves on the scientific advisory board of the Pelizaeus-Merzbacher Foundation, the Yaya Foundation Scientific and Clinical Advisory Council, and is the Chair of the Medical and Scientific Advisory Board of the United Leukodystrophy Foundation. She is a member of the Vanishing White Matter Consortium, H-ABC Clinical Advisory Board, MLC Clinical Expert Consortium, and the Chair of the POLR3-related (4H) Leukodystrophy Consortium. She is on the editorial boards of Neurology Genetics, Frontiers in Neurology\u2014Neurogenetics, and Journal of Medical Genetics. All other authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}